|
|
 |
. . . 200 / 40 .
KRKA
1635 . |
! |
 |
|
|
|
 |
. /. 0,5 2 / 10 .
GlaxoSmithKline Australia
|
|
|
 |
/. . 500 /1 (60 ) / 1 .
Glaxo Wellcome
|
|
|
 |
/. . 250 /1 (120 ) / 1 .
Glaxo Wellcome
10970 . |
! |
|
|
|
|
 |
. /., . . 250 , / 60 .
Adamed
|
|
|
 |
/., . . 125 / 60 .
Pabianice pharmaceutical works Polfa
4435 . |
! |
|
|
|
|
 |
. /. 12/400 . - . / 60+60 .
Novartis
|
|
|
 |
. /. 12/200 . - . / 60+60 .
Novartis
|
|
|
 |
. /., . . 12 , / 60 .
Inteli Generics Nord
3554 . |
! |
|
|
|
|
 |
200 /100 . 150 / 1 .
Servier
|
|
|
|
|
